XtalPi
Pierre Fabre and XtalPi Partner on AI-Based Drug Discovery
Laboratoires Pierre Fabre and XtalPi have agreed to collaborate on discovering novel clinical candidates for oncology, potentially dermatology, and rare diseases. XtalPi…
Pierre Fabre and XtalPi Partner on AI-Driven Drug Discovery
Laboratoires Pierre Fabre and XtalPi have agreed to collaborate on discovering clinical drug candidates using artificial intelligence and robotics. The research will…
Pierre Fabre and XtalPi Partner on AI-Driven Drug Discovery
Les Laboratoires Pierre Fabre and XtalPi have agreed to collaborate on discovering clinical candidates for oncology research programs, with potential applications in…
Pierre Fabre and XtalPi Form AI Drug Discovery Partnership
Laboratoires Pierre Fabre and XtalPi have agreed to collaborate on discovering clinical candidates for oncology programs and potentially dermatology and rare diseases.…
XtalPi Names First In-House siRNA Candidate for IgA Nephropathy in Nine Months
XtalPi Holdings Limited (HKEX: 2228) has nominated its first internally developed siRNA preclinical candidate for IgA nephropathy, a program it says took nine months…